Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02846935
Title p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
Recruitment Completed
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Yogen Saunthararajah
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.